Clarithromycin moa?

What is clarithromycin, and what does it do in the body?

Clarithromycin is a macrolide antibiotic. Its mechanism of action (MOA) is to inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit. This binding blocks peptide-chain elongation, which stops bacteria from making proteins they need to grow and reproduce.

How does it bind the ribosome, and what step of protein synthesis does it block?

Clarithromycin targets the bacterial 50S ribosome and interferes with the elongation process during translation (peptide-chain growth). By preventing normal elongation, it reduces production of essential bacterial proteins and leads to inhibition of bacterial growth.

Does clarithromycin kill bacteria or just stop them from growing?

Clarithromycin is generally described as bacteriostatic against susceptible organisms, meaning it mainly inhibits growth rather than rapidly killing bacteria outright. The practical effect depends on the organism and drug concentration at the infection site.

Is clarithromycin similar to other macrolides (like azithromycin or erythromycin)?

Yes. Clarithromycin’s MOA is shared across the macrolide class: binding to the bacterial 50S ribosomal subunit and blocking protein synthesis by inhibiting peptide-chain elongation. Differences between macrolides are more about spectrum, pharmacokinetics, and side-effect profiles than the core MOA.